Journal Article (Erratum/Correction)

DKFZ-2026-00247

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

Mazur, P. K. ; Herner, A. ; Mello, S. S. ; Wirth, M. ; Hausmann, S. ; Sánchez-Rivera, F. J. ; Lofgren, S. M. ; Kuschma, T. ; Hahn, S. A. ; Vangala, D. ; Trajkovic-Arsic, M. ; Gupta, A. ; Heid, I. ; Noël, P. B. ; Braren, R. ; Erkan, M. ; Kleeff, J. ; Sipos, B. ; Sayles, L. C. ; Heikenwälder, M.DKFZ* ; Heßmann, E. ; Ellenrieder, V. ; Esposito, I. ; Jacks, T. ; Bradner, J. E. ; Khatri, P. ; Sweet-Cordero, E. A. ; Attardi, L. D. ; Schmid, R. M.DKFZ* ; Schneider, G. ; Sage, J. ; Siveke, J.DKFZ*

2026
Springer Nature [New York, NY]

Abstract: In the version of the article initially published, Fig. 3b included incorrect western blot datafor “MYC”, which was a duplication of “BCL-XL”. The correct “MYC” expression data have beenlocated, and an updated version of Fig. 3 is shown as Fig. 1, below. This notice serves to amendthe error.

Note: epub

---

Contributing Institute(s):

1. Chronische Entzündung und Krebs (D440)
2. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Nature ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 80 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---